Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.

The average consumer could pay 75 percent more for a marketplace plan, according to a KFF analysis, driven by the expiration ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Affordable Care Act insurers are proposing their steepest premium increases since 2018, driven in part by the looming ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...